ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is a heterogeneous disease characterized by lack of or minimal expression of estrogen receptor (ER) and progesterone receptor (PR) and lack of overexpression and/or amplification of human epidermal growth factor receptor 2 (HER2).